Skip to main content
1-877-936-8422
VICC
Search
Main navigation
Home
Patient Care
Cancer Care Overview
Find a Doctor
Request an Appointment
Find a Clinical Trial
MyHealth at Vanderbilt
Support & Education
Cancer Information
Clinical Trials
Clinical Trials Overview
Frequently Asked Questions
Trial Search for Physicians
Trial Search For Patients
Flowcharts
Research
Research Overview
Research Programs
Shared Resources
Clinical Trials
Member Directory
Membership Information
Funding Opportunities
Seminars & Lectures
Giving
Giving & Impact
Make a Gift
Donor-Supported Research
Volunteer
Community
Community Overview
Advocacy
VICC Ambassadors
Education
Education, Training, and Career Development
Annual Scientific Retreat
About
About Vanderbilt-Ingram
Leadership
Fast Facts
History
Careers
For Media
More
Intranet (for faculty and staff)
About the site
Help
Contact the web team
Prices
Search
at Vanderbilt-Ingram Cancer Center
Site Search
All
Pages
Members
Clinical Trials
News
1031 results found
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Relevance:
1
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)
Relevance:
1
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Relevance:
1
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Relevance:
1
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
Relevance:
1
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Relevance:
1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Relevance:
1
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Relevance:
1
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Relevance:
1
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
Relevance:
1
Pagination
Previous page
‹ previous
…
Page
42
Page
43
Page
44
Page
45
Current page
46
Page
47
Page
48
Page
49
Page
50
…
Next page
next ›